Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

All Specialties

OpiCalc Logo
FavoritesSpecialtiesDrugsGuidelinesMost Used
FavesSpecsDrugsGuidesTop
APGAR ScoreAssisted Delivery (FIGO)BPP (Manning Score)Bishop ScoreCARPREG II Cardiac RiskCervical Cancer StagingContraceptive Pearl IndexDoppler Matrix (UA/MCA)EFW (Hadlock)Endometrial StagingEndometrial ThicknessFGR Criteria (Consensus)FSFI (Sexual Function)Ferriman-Gallwey ScoreFetal Anemia (MCA PSV)GDM Diagnostic CriteriaGPA History IndicatorGail Model Breast RiskGestational Dating (LMP)HIV PMTCT ProtocolIOTA Simple RulesIVF Due Date & AMHIron Deficit (Ganzoni)Labour Progress (WHO)Maternal Sepsis (qSOFA)O-RADS ClassificationOvarian Cancer StagingPAS Hemorrhage RiskPPH Protocol (FIGO)Preeclampsia (ACOG)Rho(D) Dose (K-B)Rotterdam PCOS CriteriaSyphilis ManagementTORCH FrameworkVBAC Success ProbabilityVulvar Cancer StagingWeight Gain (IOM)mWHO Cardiac Risk
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2018-2026

•

All Rights Reserved

Recent Journal Updates

DiabetologiaJun 6, 2026
Time-restricted eating versus dietetic guidance on glycaemic outcomes in adults at risk of type 2 diabetes: a non-inferiority randomised clinical trial

Clinical Context

We think this has broad domain relevance to Contraceptive Pearl Index (PI).

DiabetologiaJun 5, 2026
MASLD, diabetes and PMOS across the female life stages

Clinical Context

We think this has broad domain relevance to Contraceptive Pearl Index (PI).

PLOS MedicineMay 20, 2026
Prescribed hormonal contraceptive use trends in the Estonian Biobank: A longitudinal observational study

Clinical Context

We think this might be relevant to the clinical guidance for Contraceptive Pearl Index (PI).

Contraceptive Pearl Index

EffectivenessChance of Pregnancy Over Time

Your Details

Ready to Calculate

Choose a birth control method and how many years you plan to use it to see your chance of getting pregnant.

Guidelines & Evidence

Verified

Last Review: 2026

When to Use

What is the Pearl Index?

The Pearl Index (PI) is a standardized metric for contraceptive effectiveness, representing the expected number of unintended pregnancies per 100 women using a specific contraceptive method for exactly one year. A lower index directly translates to higher contraceptive effectiveness. The index is the primary efficacy endpoint required by the FDA and EMA for all Phase III contraceptive clinical trials. It allows direct comparison of effectiveness across different contraceptive methods, study populations, and time periods—provided that study populations are comparable.

Primary Clinical Applications

Comparing contraceptive methods: The PI enables standardized comparison of theoretical (perfect use) and real-world (typical use) effectiveness across all contraceptive options
Regulatory approval: FDA and EMA mandate the PI as the primary endpoint for contraceptive clinical trials; new methods must demonstrate non-inferiority to established methods
Patient counseling: The PI translates complex biostatistical data into an understandable metric: "On this method, roughly X out of 100 women will become pregnant each year"
Clinical trial design: PI calculations inform sample size determinations for contraceptive efficacy trials (e.g., non-inferiority margin of 2-3 PI points)
Post-marketing surveillance: Comparing PIs from clinical trials to real-world observational studies helps identify gaps between perfect and typical use
Health economic modeling: PI values are incorporated into cost-effectiveness analyses comparing contraceptive methods (e.g., LARC vs OCPs)

Perfect Use vs Typical Use: The Critical Distinction

Perfect Use (Theoretical Effectiveness): The failure rate when the method is used exactly according to instructions, with zero human error, no missed doses, and perfect adherence. This represents the method's intrinsic efficacy under ideal conditions (e.g., clinical trial strict protocol adherence). Typical Use (Real-World Effectiveness): The failure rate accounting for human error, inconsistent application, missed doses, delays, drug interactions, and user forgetfulness. This represents how the method performs for the average person in real-world settings (e.g., observational studies, large cohort trials). Clinical Significance: The delta between perfect and typical use indicates the method's "forgiveness." Long-acting reversible contraceptives (LARCs: IUDs, implants) have virtually identical perfect and typical PIs (<0.1-0.8), making them vastly superior in real-world populations. User-dependent methods (pills, patches, rings) have large deltas (perfect: 0.3 vs typical: 7-9), meaning real-world effectiveness depends heavily on user adherence and demographics.

Related Scores in Practice

In clinical practice, this assessment is frequently evaluated alongside other validated measures. Depending on the patient's presentation and specific diagnostic requirements, you may also need to utilize the Contraceptive Counseling Tool, Larc Decision Aid or the Contraceptive Medical Eligibility Criteria to formulate a comprehensive care plan.

Last Comprehensive Review: 2026